Mancini Anthony sold RVMD

September 10, 2026 · Form 4 insider transaction

Mancini Anthony sold 6,019 shares of Revolution Medicines, Inc. at $203.28 per share, a transaction worth $1.22M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
6,019
Price
$203.28
Total value
$1.22M
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 10, 2026
Filing dateSeptember 14, 2026
Shares owned after53,319
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.; The transaction was executed in multiple trades at prices ranging from $202.64 to $203.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR